{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:39:20Z","timestamp":1792546760125,"version":"4.5.0"},"reference-count":561,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The World Journal of Biological Psychiatry"],"published-print":{"date-parts":[[2021,9,14]]},"DOI":"10.1080\/15622975.2021.1878427","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:34:51Z","timestamp":1620826491000},"page":"561-628","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":42,"title":["Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-0230","authenticated-orcid":false,"given":"C. B.","family":"Eap","sequence":"first","affiliation":[{"name":"Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne","place":["Lausanne, Switzerland"]},{"name":"Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne","place":["Lausanne, Switzerland"]},{"name":"School of Pharmaceutical Sciences, University of Geneva","place":["Geneva, Switzerland"]},{"name":"Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva","place":["Geneva, Switzerland"]},{"name":"Institute of Pharmaceutical Sciences of Western Switzerland, University of Lausanne","place":["Switzerland, Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-3903","authenticated-orcid":false,"given":"G.","family":"Gr\u00fcnder","sequence":"additional","affiliation":[{"name":"Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg","place":["Mannheim, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-5225","authenticated-orcid":false,"given":"P.","family":"Baumann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Lausanne University Hospital and University of Lausanne","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ansermot","sequence":"additional","affiliation":[{"name":"Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Conca","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Health Service District Bolzano","place":["Bolzano, Italy"]},{"name":"Department of Child and Adolescent Psychiatry, South Tyrolean Regional Health Service","place":["Bolzano, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Corruble","sequence":"additional","affiliation":[{"name":"INSERM CESP, Team \u226aMOODS\u226b, Service Hospitalo-Universitaire de Psychiatrie, Universite Paris Saclay, Le Kremlin Bicetre, France"},{"name":"Service Hospitalo-Universitaire de Psychiatrie, H\u00f4pital Bic\u00eatre, Assistance Publique H\u00f4pitaux de Paris, Le Kremlin Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-7194","authenticated-orcid":false,"given":"S.","family":"Crettol","sequence":"additional","affiliation":[{"name":"Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Dahl","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2314","authenticated-orcid":false,"given":"J.","family":"de Leon","sequence":"additional","affiliation":[{"name":"Eastern State Hospital, University of Kentucky Mental Health Research Center","place":["Lexington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Greiner","sequence":"additional","affiliation":[{"name":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte","place":["Bonn, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Howes","sequence":"additional","affiliation":[{"name":"King\u2019s College London and MRC London Institute of Medical Sciences (LMS)-Imperial College","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences","place":["Seoul, South Korea"]},{"name":"Department of Psychiatry, Seoul National University College of Medicine","place":["Seoul, South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4641-9539","authenticated-orcid":false,"given":"R.","family":"Lanzenberger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Campbell Family Mental Health Research Institute, CAMH and Department of Psychiatry, University of Toronto","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Moessner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of T\u00fcbingen","place":["T\u00fcbingen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Wilhelmina Hospital Assen","place":["Assen, The Netherlands"]},{"name":"GGZ Drenthe Mental Health Services Drenthe","place":["Assen, The Netherlands"]},{"name":"Department of Pharmacotherapy, Epidemiology and Economics, Department of Pharmacy and Pharmaceutical Sciences, University of Groningen","place":["Groningen, The Netherlands"]},{"name":"Department of Psychiatry, Interdisciplinary Centre for Psychopathology and Emotion Regulation, University of Groningen","place":["Groningen, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health","place":["Toronto, Canada"]},{"name":"Department of Psychiatry, University of Toronto","place":["Toronto, Canada"]},{"name":"Department of Pharmacology and Toxicology, University of Toronto","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reis","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]},{"name":"Clinical Chemistry and Pharmacology, Sk\u00e5ne University Hospital","place":["Lund, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Riederer","sequence":"additional","affiliation":[{"name":"Center of Mental Health, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]},{"name":"Department of Psychiatry, University of Southern Denmark Odense","place":["Odense, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6072-0358","authenticated-orcid":false,"given":"H. G.","family":"Ruhe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Radboudumc","place":["Nijmegen, the Netherlands"]},{"name":"Donders Institute for Brain, Cognition and Behavior, Radboud University","place":["Nijmegen, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Spigset","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, St. Olav University Hospital","place":["Trondheim, Norway"]},{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology","place":["Trondheim, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-7449","authenticated-orcid":false,"given":"E.","family":"Spina","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina","place":["Messina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Stegman","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pharmazie der Universit\u00e4t Regensburg","place":["Regensburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Steimer","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry and Pathobiochemistry, Technical University of Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stingl","sequence":"additional","affiliation":[{"name":"Institute for Clinical Pharmacology, University Hospital of RWTH Aachen","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Suzen","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Faculty of Pharmacy, Ankara University","place":["Ankara, Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine","place":["Shinjuku-ku, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Unterecker","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-2047","authenticated-orcid":false,"given":"F.","family":"Vandenberghe","sequence":"additional","affiliation":[{"name":"Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2820-8738","authenticated-orcid":false,"given":"C.","family":"Hiemke","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center Mainz","place":["Mainz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2010.175"},{"key":"e_1_3_3_3_1","unstructured":"ABCB1 Clinical Annotations. 2020. [accessed Oct 12]. https:\/\/www.pharmgkb.org\/gene\/PA267\/clinicalAnnotation."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1984.tb04167.x"},{"key":"e_1_3_3_5_1","unstructured":"Abilify (aripiprazole) - FDA. 20XX Sunovion Pharmaceuticals Inc. 2002. [updated 2014 Dec; accessed 2020 Jun 27]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/021436s038 021713s030 021729s022 021866s023lbl.pdf."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-005-0579-5"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20109"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01858.x"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199426030-00004"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7003.485"},{"key":"e_1_3_3_11_1","unstructured":"Annotation of DPWG Guideline for paroxetine and CYP2D6. 2018. [accessed 2019 Apr 19]. https:\/\/www.pharmgkb.org\/guideline\/PA166104976."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2014.67"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00342-5"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2011.00810.x"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2012.00886.x"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.08.016"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5726.18"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5770.331"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c13-00800"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c12-00719"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.02.024"},{"key":"e_1_3_3_22_1","unstructured":"Auspar-milnacipran-hydrochloride-120124.pdf. 2012. [accessed 2019 Apr]. http:\/\/www.tga.gov.au\/file\/1303\/download."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200209000-00003"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006901900106"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000135"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31821160c4"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199120060-00002"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1996.tb00051.x"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000239795.14202.c3"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-832687"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2016.1149219"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2013.06.005"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198309000-00009"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00010"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32835d9ab0"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajem.2000.9287"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02190274"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.3.289"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.144"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90094-9"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01548.x"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1479"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0098-0"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00544066"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181ceecc6"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-012-0305-6"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.65"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0061-5"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.08.003"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000173"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145799001686"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.83"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000465"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0773.2002.900306.x"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-200033482"},{"key":"e_1_3_3_56_1","unstructured":"Brintellix: European Public Assessment Report: Summary of product characteristics. 2014. [accessed 2019 Apr]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002717\/WC500159449.pdf."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.127494"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100116"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.16.18"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S80886"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-017-0310-6"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2015.12.009"},{"issue":"4","key":"e_1_3_3_63_1","first-page":"180","article-title":"Pharmacokinetics of amoxapine and its active metabolites","volume":"23","author":"Calvo B","year":"1985","unstructured":"Calvo B, Garcia MJ, Pedraz JL, Marino EL, Dominguez-Gil A. 1985. Pharmacokinetics of amoxapine and its active metabolites. Int J Clin Pharmacol Ther Toxicol. 23(4):180\u2013185.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923060-00006"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0540-y"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12692"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0162-1"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1690-1"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200312000-00014"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110201600413"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0612-7"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0117-6"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-015-0318-2"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0182-5"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S85418"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.07.005"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.297"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01366.x"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881104047284"},{"key":"e_1_3_3_81_1","unstructured":"Clinical Pharmacogenetics Implementation Consortium (CPIC). 2020 [accessed Jun 27]. https:\/\/cpicpgx.org\/."},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9535-1"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.2165\/11587620-000000000-00000"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2016.1133588"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.101005343.x"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198712000-00003"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.221"},{"key":"e_1_3_3_88_1","unstructured":"CYP2D6 Allele Nomenclature. 2015. [accessed 2019 Apr 22]. http:\/\/www.cypalleles.ki.se\/cyp2d6.htm."},{"key":"e_1_3_3_89_1","unstructured":"Cytochrome P450 2D6. 2020. [accessed Jun]. https:\/\/www.straighthealthcare.com\/cytochrome-p450-2d6.html#inducers."},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.121"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.001313"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1053\/cp.1999.v66.99720"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199605050-00007"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000197093.92559.7a"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2008.00067.x"},{"issue":"4","key":"e_1_3_3_96_1","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"57","author":"de Boer T.","year":"1996","unstructured":"de Boer T. 1996. The pharmacologic profile of mirtazapine. J Clin Psychiatry. 57(4):19\u201325.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.01.001"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000522"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.660918"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0103"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2010.39"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199141020-00007"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.103382"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1077(200006)15:4<255::AID-HUP165>3.0.CO;2-V"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.06.024"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189334"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145799001303"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241150-00002"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03202.x"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.70"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834e9e1a"},{"key":"e_1_3_3_112_1","first-page":"46","article-title":"Sertraline: a new antidepressant","volume":"49","author":"Doogan DP","year":"1988","unstructured":"Doogan DP, Caillard V. 1988. Sertraline: a new antidepressant. J Clin Psychiatry. 49 SupplSuppl:46\u201351.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_113_1","unstructured":"Drug Label Annotations. 2019. [accessed 2019 Apr]. https:\/\/www.pharmgkb.org\/labelAnnotations."},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198707000-00005"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2016.18.3\/ceap"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200004000-00012"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-7975"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200106000-00013"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00121-6"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0762-z"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0767-7"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100120"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199802000-00002"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200301000-00006"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199904000-00005"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2009.11.077"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2319-z"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.187"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-0606-5240"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900022513"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2011.563878"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1912-y"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.58"},{"key":"e_1_3_3_134_1","unstructured":"European Medicines Agency: Valdoxan: European public assessment report: Summary of product characteristics. 2009. [updated 2018 Dec; accessed 2019 Apr]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000915\/WC500046227.pdf."},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4737"},{"key":"e_1_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371405900202"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2018.05.009"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-012-0010-5"},{"key":"e_1_3_3_139_1","unstructured":"FDA Approved Drug Products. 2011. [updated 2018 Mar; accessed 2019 Apr]. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm."},{"key":"e_1_3_3_140_1","unstructured":"FDA drug safety comunication: Revised recomendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. 2012. U.S. Food and Drug Administration; [accessed 2019 April]. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm297391.htm."},{"key":"e_1_3_3_141_1","unstructured":"FDA version 4.4.19. FDA issues warning letter to genomics lab for illegally marketing genetic test that claims to predict patients\u2019 responses to specific medications. 2020. (version 4.4.19). [accessed Apr]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-issues-warning-letter-genomics-lab-illegally-marketing-genetic-test-claims-predict-patients."},{"key":"e_1_3_3_142_1","unstructured":"FDA version 11.1.18. The FDA warns against the use of many genetic tests with unapproved claims to predict patient response to specific medications: FDA safety communication (version 11.1.18). 2020. [updated 2018 Jan 11; accessed Apr]. https:\/\/www.fda.gov\/medical-devices\/safety-communications\/fda-warns-against-use-many-genetic-tests-unapproved-claims-predict-patient-response-specific."},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.09.026"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300960"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04293.x"},{"key":"e_1_3_3_146_1","first-page":"127","article-title":"The stereoselective metabolism of fluoxetine in poor and extensive metabolisers of sparteine","volume":"52","author":"Fjordside L","year":"1997","unstructured":"Fjordside L, Jeppesen U, Eap CB, Powell K, Baumann P, Brosen K. 1997. The stereoselective metabolism of fluoxetine in poor and extensive metabolisers of sparteine. Eur J Clin Pharmacol. 52:A:127.","journal-title":"Eur J Clin Pharmacol"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039060-00003"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199901)20:1<53::AID-BDD157>3.0.CO;2-P"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.151"},{"key":"e_1_3_3_150_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.14065"},{"key":"e_1_3_3_151_1","doi-asserted-by":"publisher","DOI":"10.2165\/11207550-000000000-00000"},{"key":"e_1_3_3_152_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721070-00004"},{"key":"e_1_3_3_153_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432209"},{"key":"e_1_3_3_154_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-38087"},{"key":"e_1_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442818"},{"key":"e_1_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.10.007"},{"key":"e_1_3_3_157_1","unstructured":"Full prescribing information for Wellbutrin (revised 11\/2019). 1985. GlaxoSmithKline; [updated 2019 Nov; accessed 2019 Apr]. https:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Wellbutrin_Tablets\/pdf\/WELLBUTRIN-TABLETS-PI-MG.PDF."},{"key":"e_1_3_3_158_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013501994"},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.3038"},{"key":"e_1_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30217-2"},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.80"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019532"},{"key":"e_1_3_3_163_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2012.12020237"},{"key":"e_1_3_3_164_1","unstructured":"Genetic testing statement. 2020. ISPG (International Society of Psychiatric Genetics; [accessed 2020 Jun]. https:\/\/ispg.net\/genetic-testing-statement\/."},{"key":"e_1_3_3_165_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050572"},{"key":"e_1_3_3_166_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0710-3"},{"key":"e_1_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31817d6f5d"},{"key":"e_1_3_3_168_1","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.130131"},{"key":"e_1_3_3_169_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2124-13.2013"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-864121"},{"key":"e_1_3_3_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707253"},{"key":"e_1_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600197"},{"key":"e_1_3_3_173_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17ac11813"},{"key":"e_1_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.04.002"},{"key":"e_1_3_3_175_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800260055007"},{"key":"e_1_3_3_176_1","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2013-0008"},{"key":"e_1_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.3.399"},{"key":"e_1_3_3_178_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2016.1133587"},{"key":"e_1_3_3_179_1","unstructured":"Government of Canada Drug Product Database online. Product monograph venlafaxine XR extended release capsules. 2012. Mississauga ON Canada: Cobalt Pharmaceuticals Company; [updated 2012 Mar 29; accessed 2019 Apr]. https:\/\/pdf.hres.ca\/dpd_pm\/00016023.PDF."},{"key":"e_1_3_3_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90230-9"},{"key":"e_1_3_3_181_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-864120"},{"key":"e_1_3_3_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.01.003"},{"key":"e_1_3_3_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.04.027"},{"key":"e_1_3_3_184_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.132"},{"key":"e_1_3_3_185_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199733040-00002"},{"key":"e_1_3_3_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(91)90160-D"},{"key":"e_1_3_3_187_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1286282"},{"key":"e_1_3_3_188_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2806"},{"key":"e_1_3_3_189_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199508001-00014"},{"key":"e_1_3_3_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.01.016"},{"key":"e_1_3_3_191_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000203225.79364.85"},{"key":"e_1_3_3_192_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2004.tb00002.x"},{"key":"e_1_3_3_193_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(67)90218-4"},{"issue":"5","key":"e_1_3_3_194_1","first-page":"593","article-title":"A comparison of the neurochemical properties of the stereoisomers of tranylcypromine in the central nervous system","volume":"32","author":"Hampson DR","year":"1986","unstructured":"Hampson DR, Baker GB, Coutts RT. 1986. A comparison of the neurochemical properties of the stereoisomers of tranylcypromine in the central nervous system. Cell Mol Biol. 32(5):593\u2013599.","journal-title":"Cell Mol Biol"},{"key":"e_1_3_3_195_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e328345ca37"},{"key":"e_1_3_3_196_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200010000-00003"},{"key":"e_1_3_3_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.10.015"},{"key":"e_1_3_3_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(96)00023-5"},{"key":"e_1_3_3_199_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016478708902"},{"key":"e_1_3_3_200_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-016-0692-7"},{"key":"e_1_3_3_201_1","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.130055"},{"key":"e_1_3_3_202_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200023338017"},{"key":"e_1_3_3_203_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0429-7"},{"key":"e_1_3_3_204_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01874.x"},{"key":"e_1_3_3_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60095-0"},{"key":"e_1_3_3_206_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1661"},{"key":"e_1_3_3_207_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.147"},{"key":"e_1_3_3_208_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.597"},{"key":"e_1_3_3_209_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.2"},{"key":"e_1_3_3_210_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000582"},{"key":"e_1_3_3_211_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1286287"},{"issue":"1","key":"e_1_3_3_212_1","first-page":"9","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke C","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, et\u00a0al. 2018. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 51(1\u201302):9\u201362.","journal-title":"Pharmacopsychiatry"},{"key":"e_1_3_3_213_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(99)00048-0"},{"key":"e_1_3_3_214_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s4369"},{"key":"e_1_3_3_215_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.484"},{"key":"e_1_3_3_216_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600323"},{"key":"e_1_3_3_217_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000138424.33979.0C"},{"key":"e_1_3_3_218_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110376691"},{"key":"e_1_3_3_219_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549020-00010"},{"key":"e_1_3_3_220_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2696"},{"key":"e_1_3_3_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00222-5"},{"key":"e_1_3_3_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2011.07.002"},{"key":"e_1_3_3_223_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2012.06.002"},{"key":"e_1_3_3_224_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198612000-00003"},{"key":"e_1_3_3_225_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111414451"},{"key":"e_1_3_3_226_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31135-3"},{"key":"e_1_3_3_227_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.044610"},{"key":"e_1_3_3_228_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01244820"},{"key":"e_1_3_3_229_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010372105"},{"key":"e_1_3_3_230_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.048108"},{"key":"e_1_3_3_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90640-0"},{"key":"e_1_3_3_232_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15030331"},{"key":"e_1_3_3_233_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm400770g"},{"key":"e_1_3_3_234_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182664d98"},{"key":"e_1_3_3_235_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629090-00001"},{"key":"e_1_3_3_236_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.11.011"},{"key":"e_1_3_3_237_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301646"},{"key":"e_1_3_3_238_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0445-6"},{"key":"e_1_3_3_239_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050452"},{"key":"e_1_3_3_240_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645110-00002"},{"issue":"263","key":"e_1_3_3_241_1","first-page":"362","article-title":"Chlordiazepoxide and dothiepin compared in anxiety-depression in general practice","volume":"211","author":"Johnson F","year":"1973","unstructured":"Johnson F, Sacco FA, Yellowley TW. 1973. Chlordiazepoxide and dothiepin compared in anxiety-depression in general practice. Practitioner. 211(263):362\u2013364.","journal-title":"Practitioner"},{"key":"e_1_3_3_242_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.105"},{"key":"e_1_3_3_243_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17050550"},{"key":"e_1_3_3_244_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.204"},{"key":"e_1_3_3_245_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109105457"},{"key":"e_1_3_3_246_1","doi-asserted-by":"publisher","DOI":"10.2190\/PM.37.3.h"},{"key":"e_1_3_3_247_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00204-2"},{"key":"e_1_3_3_248_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.01.003"},{"key":"e_1_3_3_249_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.04.004"},{"key":"e_1_3_3_250_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2014.50"},{"key":"e_1_3_3_251_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(93)90290-3"},{"key":"e_1_3_3_252_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32832a8ec8"},{"key":"e_1_3_3_253_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1375618"},{"key":"e_1_3_3_254_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.116"},{"key":"e_1_3_3_255_1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.6"},{"key":"e_1_3_3_256_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb07176.x"},{"key":"e_1_3_3_257_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.10010"},{"key":"e_1_3_3_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.10.024"},{"key":"e_1_3_3_259_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1218-8"},{"key":"e_1_3_3_260_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199510000-00004"},{"key":"e_1_3_3_261_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903286396"},{"key":"e_1_3_3_262_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008314254"},{"key":"e_1_3_3_263_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000020"},{"key":"e_1_3_3_264_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2011.07.034"},{"key":"e_1_3_3_265_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00299.x"},{"key":"e_1_3_3_266_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000167331.30905.9e"},{"key":"e_1_3_3_267_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000145341.30547.f0"},{"key":"e_1_3_3_268_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200310000-00005"},{"key":"e_1_3_3_269_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200210000-00010"},{"key":"e_1_3_3_270_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000088909.24613.92"},{"key":"e_1_3_3_271_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001494"},{"key":"e_1_3_3_272_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200312000-00003"},{"key":"e_1_3_3_273_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0486-0"},{"key":"e_1_3_3_274_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0666-y"},{"key":"e_1_3_3_275_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(99)00009-8"},{"key":"e_1_3_3_276_1","doi-asserted-by":"publisher","DOI":"10.2165\/11539240-000000000-00000"},{"key":"e_1_3_3_277_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90606-5"},{"key":"e_1_3_3_278_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)36462-6"},{"key":"e_1_3_3_279_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)15222-1"},{"key":"e_1_3_3_280_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)26381-9"},{"key":"e_1_3_3_281_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.120196"},{"key":"e_1_3_3_282_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000946"},{"key":"e_1_3_3_283_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)20103-3"},{"key":"e_1_3_3_284_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1981.tb01587.x"},{"key":"e_1_3_3_285_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2016.1254802"},{"key":"e_1_3_3_286_1","doi-asserted-by":"publisher","DOI":"10.1038\/86882"},{"key":"e_1_3_3_287_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300036"},{"key":"e_1_3_3_288_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP45036"},{"key":"e_1_3_3_289_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114543720"},{"issue":"2","key":"e_1_3_3_290_1","first-page":"247","article-title":"Serum levels of maprotiline and its adverse effects on depressed patients","volume":"41","author":"Kurata K","year":"1987","unstructured":"Kurata K, Kido H, Hasegawa M, Inoue M, Yamaguchi N. 1987. Serum levels of maprotiline and its adverse effects on depressed patients. Jpn J Psychiatry Neurol. 41(2):247\u2013254.","journal-title":"Jpn J Psychiatry Neurol"},{"key":"e_1_3_3_291_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000042"},{"key":"e_1_3_3_292_1","doi-asserted-by":"publisher","DOI":"10.1177\/030006057400200305"},{"key":"e_1_3_3_293_1","unstructured":"Lamictal (lamotrigine) - FDA. 1994. GlaxoSmithKline; [updated 2017 Sep; accessed 2020 Jun 27]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020241s045s051lbl.pdf."},{"key":"e_1_3_3_294_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198938010-00005"},{"key":"e_1_3_3_295_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.9.1142"},{"key":"e_1_3_3_296_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.07.023"},{"key":"e_1_3_3_297_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198900381-00006"},{"key":"e_1_3_3_298_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.62030978.x"},{"key":"e_1_3_3_299_1","unstructured":"Latuda (lurasidone hydrochloride) - FDA. GlaxoSmithKline; 2010 [updated 2013; accessed 2020 Jun 27]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/200603lbls10s11.pdf."},{"key":"e_1_3_3_300_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01834-6"},{"key":"e_1_3_3_301_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00121-8"},{"key":"e_1_3_3_302_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199912000-00003"},{"key":"e_1_3_3_303_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00011"},{"key":"e_1_3_3_304_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.110.082727"},{"key":"e_1_3_3_305_1","doi-asserted-by":"publisher","DOI":"10.2165\/0003088-200948010-00005"},{"key":"e_1_3_3_306_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P772"},{"key":"e_1_3_3_307_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.1r084.x"},{"key":"e_1_3_3_308_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00402639"},{"key":"e_1_3_3_309_1","unstructured":"Lithium carbonate tablets USP Lithium carbonate capsules USP Lithium oral solution USP - FDA. Columbus (OH): Roxane Laboratories Inc.; 2011 [accessed 2020 Jun 27]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/017812s028 018421s027lbl.pdf."},{"key":"e_1_3_3_310_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.105"},{"key":"e_1_3_3_311_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0707-y"},{"key":"e_1_3_3_312_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04773blu"},{"key":"e_1_3_3_313_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00102"},{"key":"e_1_3_3_314_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145706007486"},{"key":"e_1_3_3_315_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.101005354.x"},{"key":"e_1_3_3_316_1","doi-asserted-by":"publisher","DOI":"10.1038\/184547b0"},{"key":"e_1_3_3_317_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00188.x"},{"key":"e_1_3_3_318_1","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2013-0053"},{"key":"e_1_3_3_319_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145705006462"},{"key":"e_1_3_3_320_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199702000-00006"},{"key":"e_1_3_3_321_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16050617"},{"key":"e_1_3_3_322_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(01)00308-0"},{"key":"e_1_3_3_323_1","doi-asserted-by":"publisher","DOI":"10.2165\/11599770-000000000-00000"},{"key":"e_1_3_3_324_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529050-00002"},{"key":"e_1_3_3_325_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181fcf94d"},{"key":"e_1_3_3_326_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.165"},{"key":"e_1_3_3_327_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00509-3"},{"key":"e_1_3_3_328_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.03.024"},{"key":"e_1_3_3_329_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2014.16.3\/amenke"},{"key":"e_1_3_3_330_1","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2014-0009"},{"key":"e_1_3_3_331_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.11.1209"},{"key":"e_1_3_3_332_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1166-3"},{"key":"e_1_3_3_333_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.1.78"},{"key":"e_1_3_3_334_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1843"},{"key":"e_1_3_3_335_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.5.826"},{"key":"e_1_3_3_336_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.156"},{"key":"e_1_3_3_337_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0773.2001.d01-115.x"},{"key":"e_1_3_3_338_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050376"},{"key":"e_1_3_3_339_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199712000-00005"},{"key":"e_1_3_3_340_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200208000-00016"},{"key":"e_1_3_3_341_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(02)00082-3"},{"key":"e_1_3_3_342_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.243"},{"key":"e_1_3_3_343_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250600718464"},{"key":"e_1_3_3_344_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198908000-00009"},{"key":"e_1_3_3_345_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb01600.x"},{"key":"e_1_3_3_346_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb05867.x"},{"key":"e_1_3_3_347_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx069"},{"key":"e_1_3_3_348_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(03)00138-2"},{"key":"e_1_3_3_349_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(80)90599-7"},{"key":"e_1_3_3_350_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(75)90029-5"},{"key":"e_1_3_3_351_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200412000-00007"},{"key":"e_1_3_3_352_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-33199"},{"key":"e_1_3_3_353_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.05.053"},{"key":"e_1_3_3_354_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.3.311"},{"key":"e_1_3_3_355_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP49003"},{"key":"e_1_3_3_356_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2010.535810"},{"key":"e_1_3_3_357_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.65"},{"key":"e_1_3_3_358_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799436476"},{"key":"e_1_3_3_359_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110389208"},{"key":"e_1_3_3_360_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000125680.89843.a6"},{"key":"e_1_3_3_361_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712001009"},{"key":"e_1_3_3_362_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000680"},{"key":"e_1_3_3_363_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)90642-4"},{"key":"e_1_3_3_364_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002428"},{"key":"e_1_3_3_365_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200304000-00006"},{"key":"e_1_3_3_366_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.06.042"},{"key":"e_1_3_3_367_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212803523699"},{"key":"e_1_3_3_368_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3182885d9d"},{"key":"e_1_3_3_369_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199304000-00008"},{"key":"e_1_3_3_370_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)37161-7"},{"key":"e_1_3_3_371_1","doi-asserted-by":"publisher","DOI":"10.30773\/pi.2017.05.22"},{"key":"e_1_3_3_372_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(62)91019-X"},{"key":"e_1_3_3_373_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.08.010"},{"key":"e_1_3_3_374_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3182708ec5."},{"issue":"4","key":"e_1_3_3_375_1","first-page":"493","article-title":"Enantio-selective LC-MS analysis of mirtazapine, desmethylmirtazapine and 8-hydroxymirtazapine in plasma of psychiatric patients","volume":"25","author":"Paus E","year":"2003","unstructured":"Paus E, Jonzier-Perey M, Cochard N, Eap CB, Baumann P. 2003. Enantio-selective LC-MS analysis of mirtazapine, desmethylmirtazapine and 8-hydroxymirtazapine in plasma of psychiatric patients. Ther Drug Monit. 25(4)Abst. N\u00b0 29):493.","journal-title":"Ther Drug Monit"},{"key":"e_1_3_3_376_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.5"},{"key":"e_1_3_3_377_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12227"},{"key":"e_1_3_3_378_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.91"},{"key":"e_1_3_3_379_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.12.010"},{"key":"e_1_3_3_380_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2011.62"},{"key":"e_1_3_3_381_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199408000-00002"},{"key":"e_1_3_3_382_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199427030-00002"},{"key":"e_1_3_3_383_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001872"},{"key":"e_1_3_3_384_1","unstructured":"PharmGKB 2016. [accessed 2019 Apr 22]. http:\/\/www.pharmgkb.org."},{"key":"e_1_3_3_385_1","unstructured":"The PharmVar Consortium. 2019. [accessed 2019 Apr]. https:\/\/www.pharmvar.org."},{"key":"e_1_3_3_386_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb00359.x"},{"key":"e_1_3_3_387_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb05875.x"},{"key":"e_1_3_3_388_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01276462"},{"key":"e_1_3_3_389_1","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.100059"},{"issue":"2","key":"e_1_3_3_390_1","first-page":"99","article-title":"Genetics and antidepressant: Where we are","volume":"8","author":"Porcelli S","year":"2011","unstructured":"Porcelli S, Fabbri C, Drago A, Gibiino S, De RD, Serretti A. 2011. Genetics and antidepressant: Where we are. Clinical Neuropsychiatry. 8(2):99\u2013150.","journal-title":"Clinical Neuropsychiatry"},{"key":"e_1_3_3_391_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.10.003"},{"key":"e_1_3_3_392_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199001001-00005"},{"key":"e_1_3_3_393_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318192e4c1"},{"issue":"5","key":"e_1_3_3_394_1","first-page":"137","article-title":"Antidepressant response and plasma concentrations of bupropion","volume":"44","author":"Preskorn SH.","year":"1983","unstructured":"Preskorn SH. 1983. Antidepressant response and plasma concentrations of bupropion. J Clin Psychiatry. 44(5\u2009Pt 2):137\u2013139.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"e_1_3_3_395_1","first-page":"24","article-title":"Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach","volume":"47","author":"Preskorn SH.","year":"1986","unstructured":"Preskorn SH. 1986. Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach. J Clin Psychiatry. 47(1 Suppl)Suppl):24\u201330.","journal-title":"J Clin Psychiatry"},{"issue":"34","key":"e_1_3_3_396_1","first-page":"43","article-title":"Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring","volume":"50","author":"Preskorn SH.","year":"1989","unstructured":"Preskorn SH. 1989. Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. J Clin Psychiatry. 50(34\u201342):43\u201336. Suppldiscussion","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_397_1","doi-asserted-by":"publisher","DOI":"10.3109\/09540269509022972"},{"key":"e_1_3_3_398_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199700321-00003"},{"key":"e_1_3_3_399_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000445247.54048.68"},{"issue":"6","key":"e_1_3_3_400_1","first-page":"23","article-title":"Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness","volume":"52","author":"Preskorn SH","year":"1991","unstructured":"Preskorn SH, Fast GA. 1991. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J Clin Psychiatry. 52 (Supp.6):23\u201333.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_401_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.12.1690"},{"key":"e_1_3_3_402_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544090-00007"},{"issue":"1","key":"e_1_3_3_403_1","first-page":"80","article-title":"Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man","volume":"34","author":"Raaflaub J","year":"1984","unstructured":"Raaflaub J, Haefelfinger P, Trautmann KH. 1984. Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man. Arzneimittelforschung. 34(1):80\u201382.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_404_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(00)00120-7"},{"key":"e_1_3_3_405_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199325060-00003"},{"key":"e_1_3_3_406_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.07.008"},{"key":"e_1_3_3_407_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200004000-00001"},{"key":"e_1_3_3_408_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.12.015"},{"key":"e_1_3_3_409_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/31.5.254"},{"key":"e_1_3_3_410_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31819114ea"},{"key":"e_1_3_3_411_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200304000-00007"},{"key":"e_1_3_3_412_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.04.058"},{"key":"e_1_3_3_413_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.6.2.217"},{"key":"e_1_3_3_414_1","first-page":"219","article-title":"Seproxetine: absolute configurations and stereospecific interactions of the enantiomers of norfluoxetine with the serotonin uptake carrier","volume":"33","author":"Robertson DW","year":"1991","unstructured":"Robertson DW, Krushinski JH, Bymaster FP, Reid LR, Wong DT. 1991. Seproxetine: absolute configurations and stereospecific interactions of the enantiomers of norfluoxetine with the serotonin uptake carrier. Pharmacologist. 33:219.","journal-title":"Pharmacologist"},{"key":"e_1_3_3_415_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199702000-00001"},{"key":"e_1_3_3_416_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199700321-00004"},{"key":"e_1_3_3_417_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15r10583"},{"issue":"6","key":"e_1_3_3_418_1","first-page":"572","article-title":"Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources","volume":"26","author":"Rotzinger S","year":"1998","unstructured":"Rotzinger S, Fang J, Baker GB. 1998. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab Dispos. 26(6):572\u2013575.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_419_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00483-6"},{"key":"e_1_3_3_420_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.009340"},{"key":"e_1_3_3_421_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0355-2"},{"key":"e_1_3_3_422_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0305"},{"key":"e_1_3_3_423_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006949816036"},{"key":"e_1_3_3_424_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-1057-x"},{"key":"e_1_3_3_425_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.148"},{"key":"e_1_3_3_426_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.018325"},{"key":"e_1_3_3_427_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32831a6a3a"},{"key":"e_1_3_3_428_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-40384-2_5"},{"key":"e_1_3_3_429_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"issue":"10","key":"e_1_3_3_430_1","first-page":"1159","article-title":"Studies on antidepressive action of prothiaden","volume":"16","author":"Rydzynski Z.","year":"1966","unstructured":"Rydzynski Z. 1966. Studies on antidepressive action of prothiaden. Neurol Neurochir Psychiatr Pol. 16(10):1159\u20131162. [].","journal-title":"Neurol Neurochir Psychiatr Pol"},{"key":"e_1_3_3_431_1","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.100117"},{"key":"e_1_3_3_432_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12938"},{"key":"e_1_3_3_433_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119827959"},{"key":"e_1_3_3_434_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2000.10.27"},{"key":"e_1_3_3_435_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-013-0028-5"},{"key":"e_1_3_3_436_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_295.x"},{"key":"e_1_3_3_437_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.07.001"},{"key":"e_1_3_3_438_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1865-z"},{"key":"e_1_3_3_439_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006986824213"},{"key":"e_1_3_3_440_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328346063f"},{"key":"e_1_3_3_441_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000003"},{"key":"e_1_3_3_442_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.31019"},{"key":"e_1_3_3_443_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-4002-2"},{"key":"e_1_3_3_444_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3146-1"},{"key":"e_1_3_3_445_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0792-6"},{"key":"e_1_3_3_446_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.169"},{"key":"e_1_3_3_447_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125311409486"},{"key":"e_1_3_3_448_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto_194.x"},{"key":"e_1_3_3_449_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1824-9"},{"key":"e_1_3_3_450_1","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(89)80026-3"},{"key":"e_1_3_3_451_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1363258"},{"key":"e_1_3_3_452_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2018.16.1.1"},{"key":"e_1_3_3_453_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32832e5b0d"},{"key":"e_1_3_3_454_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.04.003"},{"key":"e_1_3_3_455_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2006.00763.x"},{"key":"e_1_3_3_456_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31802e0017"},{"key":"e_1_3_3_457_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113017"},{"key":"e_1_3_3_458_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0097-3"},{"key":"e_1_3_3_459_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-636X(1997)9:7<686::AID-CHIR9>3.0.CO;2-5"},{"key":"e_1_3_3_460_1","doi-asserted-by":"publisher","DOI":"10.1159\/000468184"},{"key":"e_1_3_3_461_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(85)90071-0"},{"issue":"3","key":"e_1_3_3_462_1","first-page":"113","article-title":"Plasma levels and therapeutic response with trimipramine treatment of endogenous depression","volume":"49","author":"Simpson GM","year":"1988","unstructured":"Simpson GM, Pi EH, Gross L, Baron D, November M. 1988. Plasma levels and therapeutic response with trimipramine treatment of endogenous depression. J Clin Psychiatry. 49(3):113\u2013116.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_463_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.24"},{"key":"e_1_3_3_464_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.23"},{"key":"e_1_3_3_465_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199302000-00002"},{"key":"e_1_3_3_466_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.10.018"},{"key":"e_1_3_3_467_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1449-5"},{"key":"e_1_3_3_468_1","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e318227f83f"},{"key":"e_1_3_3_469_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.141796"},{"key":"e_1_3_3_470_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005280860"},{"key":"e_1_3_3_471_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12118"},{"key":"e_1_3_3_472_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80580-J"},{"key":"e_1_3_3_473_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09933.x"},{"key":"e_1_3_3_474_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01492.x"},{"key":"e_1_3_3_475_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.885504"},{"key":"e_1_3_3_476_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1154043"},{"key":"e_1_3_3_477_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(08)80047-1"},{"key":"e_1_3_3_478_1","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2013.0217"},{"key":"e_1_3_3_479_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900024020"},{"key":"e_1_3_3_480_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v06n0403"},{"key":"e_1_3_3_481_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.01.002"},{"key":"e_1_3_3_482_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12317"},{"key":"e_1_3_3_483_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.239"},{"key":"e_1_3_3_484_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1990.tb05346.x"},{"key":"e_1_3_3_485_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600731221"},{"key":"e_1_3_3_486_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.386"},{"key":"e_1_3_3_487_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04132.x"},{"key":"e_1_3_3_488_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.34"},{"key":"e_1_3_3_489_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500289"},{"issue":"6","key":"e_1_3_3_490_1","first-page":"257","article-title":"Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data","volume":"57","author":"Szegedi A","year":"1996","unstructured":"Szegedi A, Wetzel H, Leal M, H\u00e4rtter S, Hiemke C. 1996. Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data. J Clin Psychiatry. 57(6):257\u2013264.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_491_1","unstructured":"Table of Pharmacogenetic Associations. 2020. [accessed 2020 Apr]. https:\/\/www.fda.gov\/medical-devices\/precision-medicine\/table-pharmacogenetic-associations."},{"key":"e_1_3_3_492_1","unstructured":"Table of Pharmacogenomic Biomarkers in Drug Labeling. 2018. [updated 2018 Dec; accessed 2019 Apr]. https:\/\/www.fda.gov\/drugs\/science-research-drugs\/table-pharmacogenomic-biomarkers-drug-labeling."},{"key":"e_1_3_3_493_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30462"},{"key":"e_1_3_3_494_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.05.015"},{"key":"e_1_3_3_495_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2212-9"},{"key":"e_1_3_3_496_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000203201.34323.d3"},{"key":"e_1_3_3_497_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0304-0"},{"key":"e_1_3_3_498_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713001521"},{"key":"e_1_3_3_499_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0562-x"},{"key":"e_1_3_3_500_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb07201.x"},{"key":"e_1_3_3_501_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/28.10.2154"},{"key":"e_1_3_3_502_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01393-9"},{"key":"e_1_3_3_503_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.05.011"},{"key":"e_1_3_3_504_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834c6efd"},{"key":"e_1_3_3_505_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200038060-00001"},{"key":"e_1_3_3_506_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000843"},{"key":"e_1_3_3_507_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000036"},{"key":"e_1_3_3_508_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.067900"},{"key":"e_1_3_3_509_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(200008)37:2<95::AID-SYN3>3.0.CO;2-H"},{"key":"e_1_3_3_510_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.02.010"},{"key":"e_1_3_3_511_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1024"},{"key":"e_1_3_3_512_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.11.007"},{"key":"e_1_3_3_513_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241110-00004"},{"key":"e_1_3_3_514_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1559635"},{"key":"e_1_3_3_515_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997"},{"key":"e_1_3_3_516_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000070"},{"key":"e_1_3_3_517_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199500291-00003"},{"key":"e_1_3_3_518_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.598"},{"key":"e_1_3_3_519_1","unstructured":"Variant Annotations. 2020. [accessed 2020 Apr 9]. https:\/\/www.pharmgkb.org\/chemical\/PA451201\/variantAnnotation."},{"key":"e_1_3_3_520_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200004000-00011"},{"key":"e_1_3_3_521_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1998.tb04399.x"},{"key":"e_1_3_3_522_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710000374"},{"key":"e_1_3_3_523_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000764"},{"key":"e_1_3_3_524_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13050709"},{"key":"e_1_3_3_525_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0806-z"},{"key":"e_1_3_3_526_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.12.007"},{"key":"e_1_3_3_527_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109104863"},{"key":"e_1_3_3_528_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2006.04.005"},{"key":"e_1_3_3_529_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00353-9"},{"key":"e_1_3_3_530_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.020408.x"},{"key":"e_1_3_3_531_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1220890"},{"key":"e_1_3_3_532_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.116513"},{"key":"e_1_3_3_533_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002371"},{"key":"e_1_3_3_534_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317050-00004"},{"key":"e_1_3_3_535_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules19044907"},{"issue":"1","key":"e_1_3_3_536_1","first-page":"183","article-title":"Low-dose fluoxetine therapy for depression","volume":"24","author":"Wernicke JF","year":"1988","unstructured":"Wernicke JF, Dunlop SR, Dornseif BE, Bosomworth JC, Humbert M. 1988. Low-dose fluoxetine therapy for depression. Psychopharmacol Bull. 24(1):183\u2013188.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_537_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)14936-7"},{"key":"e_1_3_3_538_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0084"},{"key":"e_1_3_3_539_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.166"},{"key":"e_1_3_3_540_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1993.33"},{"issue":"3","key":"e_1_3_3_541_1","first-page":"171","article-title":"Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors","volume":"2","author":"Wong DT","year":"1990","unstructured":"Wong DT, Fuller RW, Robertson DW. 1990. Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors. Acta Pharm Nord. 2(3):171\u2013180.","journal-title":"Acta Pharm Nord"},{"key":"e_1_3_3_542_1","doi-asserted-by":"publisher","DOI":"10.1002\/chir.20356"},{"key":"e_1_3_3_543_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2015.61"},{"key":"e_1_3_3_544_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650903585937"},{"key":"e_1_3_3_545_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.106128"},{"key":"e_1_3_3_546_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106072192"},{"key":"e_1_3_3_547_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.907"},{"key":"e_1_3_3_548_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1575"},{"key":"e_1_3_3_549_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600750612"},{"key":"e_1_3_3_550_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.114231"},{"key":"e_1_3_3_551_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0259-8"},{"key":"e_1_3_3_552_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.216"},{"key":"e_1_3_3_553_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu058"},{"issue":"24","key":"e_1_3_3_554_1","first-page":"1","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger UM","year":"2013","unstructured":"Zanger UM, Klein K. 2013. Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance. Front Genet. 4(article 24):1\u201312. eng.","journal-title":"Front Genet"},{"key":"e_1_3_3_555_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17998"},{"key":"e_1_3_3_556_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.015198"},{"key":"e_1_3_3_557_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17111282"},{"key":"e_1_3_3_558_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318070-000000000-00000"},{"key":"e_1_3_3_559_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14r09204"},{"key":"e_1_3_3_560_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2015.05.002"},{"key":"e_1_3_3_561_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15873"},{"key":"e_1_3_3_562_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620120-00003"}],"container-title":["The World Journal of Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15622975.2021.1878427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:36:27Z","timestamp":1770928587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15622975.2021.1878427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":561,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,9,14]]}},"alternative-id":["10.1080\/15622975.2021.1878427"],"URL":"https:\/\/doi.org\/10.1080\/15622975.2021.1878427","relation":{},"ISSN":["1562-2975","1814-1412"],"issn-type":[{"value":"1562-2975","type":"print"},{"value":"1814-1412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iwbp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iwbp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}